363 related articles for article (PubMed ID: 30353318)
1. Non-renal-Related Mechanisms of FGF23 Pathophysiology.
Hanudel MR; Laster M; Salusky IB
Curr Osteoporos Rep; 2018 Dec; 16(6):724-729. PubMed ID: 30353318
[TBL] [Abstract][Full Text] [Related]
2. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
Czaya B; Faul C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
[TBL] [Abstract][Full Text] [Related]
3. Inflammation regulates fibroblast growth factor 23 production.
Francis C; David V
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.
Babitt JL; Sitara D
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):304-310. PubMed ID: 31145704
[TBL] [Abstract][Full Text] [Related]
5. Anemia and fibroblast growth factor 23 elevation in chronic kidney disease: homeostatic interactions and emerging therapeutics.
Agoro R; White KE
Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):320-325. PubMed ID: 35703246
[TBL] [Abstract][Full Text] [Related]
6. The role of bone in CKD-mediated mineral and vascular disease.
Khouzam NM; Wesseling-Perry K; Salusky IB
Pediatr Nephrol; 2015 Sep; 30(9):1379-88. PubMed ID: 25168424
[TBL] [Abstract][Full Text] [Related]
7. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
8. [New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period -when and how?].
Komaba H
Clin Calcium; 2014 Dec; 24(12):1771-8. PubMed ID: 25423921
[TBL] [Abstract][Full Text] [Related]
9. [FGF23 in CKD-MBD].
Fukumoto S
Nihon Jinzo Gakkai Shi; 2014; 56(8):1210-7. PubMed ID: 25551981
[No Abstract] [Full Text] [Related]
10. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
Hanudel MR; Chua K; Rappaport M; Gabayan V; Valore E; Goltzman D; Ganz T; Nemeth E; Salusky IB
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1369-F1377. PubMed ID: 27733366
[TBL] [Abstract][Full Text] [Related]
12. Associations between anemia and FGF23 in the CKiD study.
Thomas E; Klomhaus AM; Laster ML; Furth SL; Warady BA; Salusky IB; Hanudel MR
Pediatr Nephrol; 2024 Mar; 39(3):837-847. PubMed ID: 37752381
[TBL] [Abstract][Full Text] [Related]
13. Osteo-renal regulation of systemic phosphate metabolism.
Razzaque MS
IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
[TBL] [Abstract][Full Text] [Related]
14. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
16. Ironing out the cross talk between FGF23 and inflammation.
David V; Francis C; Babitt JL
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F1-F8. PubMed ID: 27582104
[TBL] [Abstract][Full Text] [Related]
17. Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.
Hanudel MR; Eisenga MF; Rappaport M; Chua K; Qiao B; Jung G; Gabayan V; Gales B; Ramos G; de Jong MA; van Zanden JJ; de Borst MH; Bakker SJL; Nemeth E; Salusky IB; Gaillard CAJM; Ganz T
Nephrol Dial Transplant; 2019 Dec; 34(12):2057-2065. PubMed ID: 30007314
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.
Rossaint J; Unruh M; Zarbock A
Nephrol Dial Transplant; 2017 Sep; 32(9):1448-1453. PubMed ID: 27659127
[TBL] [Abstract][Full Text] [Related]
19. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
Wolf M; White KE
Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
Agoro R; Montagna A; Goetz R; Aligbe O; Singh G; Coe LM; Mohammadi M; Rivella S; Sitara D
FASEB J; 2018 Jul; 32(7):3752-3764. PubMed ID: 29481308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
